IP Library Granted Patent US 10,857,266
Granted Patent B2
US 10,857,266 · App. 13/967,326 · Granted Dec 8, 2020

Reinforced placental tissue grafts and methods of making and using the same

Inventors: Thomas J. Koob (Marietta, GA); Robert Tofe (Denver, CO); Elizabeth Chen (Denver, CO)
Assignee: MiMedx Group, Inc.
A61L27/54A61F2/0063A61F2/02A61L27/14A61L27/24A61L27/36A61L27/3604A61L27/44A61L27/56A61F13/00008A61L27/3633
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,857,266
App. No.
13/967,326
Granted
Dec 8, 2020
Kind
B2
Abstract

Described herein are tissue grafts derived from the placental tissue that are reinforced with at least one biocompatible mesh. The tissue grafts possess good adhesion to biological tissues and are useful in wound healing applications. Also described herein are methods for making and using the tissue grafts.

Claims (20)

1. A reinforced tissue graft comprising:

a first membrane comprising a placental tissue having a first side and a second side;

a non-resorbable biocompatible mesh having a first side and a second side, wherein the first side of the biocompatible mesh is adjacent to the second side of the first membrane;

a second membrane comprising a placental tissue having a first side and a second side, wherein the first side of the second membrane is adjacent to the second side of the biocompatible mesh; and

optionally including from one up to nine additional membranes on either side of the biocompatible mesh,

wherein at least one of the first membrane, the second membrane, or the additional membranes comprises modified amnion having an intact epithelial cell layer,

wherein each modified amnion in the graft has an intact epithelial cell layer, and

wherein the biocompatible mesh is coated on one or both sides with micronized placental tissue.

2. The tissue graft of claim 1 , wherein the first membrane comprises amnion, chorion, or a laminate comprising one or more layers of amnion with one or more layers of chorion.

3. The tissue graft of claim 1 , wherein the second membrane comprises amnion, chorion, or a laminate comprising one or more layers of amnion with one or more layers of chorion.

4. The tissue graft of claim 1 , wherein the second membrane comprises an amnion/chorion laminate, wherein the chorion is adjacent to the second side of the biocompatible mesh.

5. The tissue graft of claim 4 , wherein the amnion comprises an intermediate layer, and wherein the chorion is adjacent to the intermediate layer.

6. The tissue graft of claim 1 , wherein the first membrane comprises Wharton's jelly.

7. The tissue graft of claim 1 , wherein the first membrane and/or second membrane are crosslinked.

8. The tissue graft of claim 1 , wherein the biocompatible mesh has a pore size from 200 microns to 4,000 microns.

9. The tissue graft of claim 1 , wherein the biocompatible mesh has a plurality of pores spaced from 1,000 microns to 4,500 microns apart as measured from the center of two pores.

10. The tissue graft of claim 1 , wherein the biocompatible mesh has a thickness of 300 microns to 2,000 microns.

11. The tissue graft of claim 1 , wherein the biocompatible mesh is made of a thermoplastic resin, polyethylene, ultra-high weight molecular weight polyethylene, high molecular weight polyolefin, uncoated monofilament polypropylene, polyether ether ketone, polyethylene terephthalate, polytetrafluoroethylene, expanded polytetrafluoroethylene, nylon, or any combination thereof.

12. The tissue graft of claim 1 , wherein the micronized placental tissue is applied to the tissue graft by wetting the biocompatible mesh to render it absorbent and contacting the biocompatible mesh with a surface having micronized placental tissue deposited thereon.

13. A wound dressing comprising the tissue graft of claim 1 .

Assignments (11)
RELEASE OF SECURITY INTEREST Recorded Feb 5, 2024
From: HAYFIN SERVICES LLP
To: MIMEDX GROUP, INC.; MIMEDX PROCESSING SERVICES, LLC
Reel/Frame 066493/0322 →
SECURITY INTEREST Recorded Jan 25, 2024
From: MIMEDX GROUP, INC.
To: CITIZENS BANK, N.A.
Reel/Frame 066371/0136 →
RELEASE OF SECURITY INTEREST Recorded Jul 2, 2020
From: BLUE TORCH FINANCE LLC, AS COLLATERAL AGENT
To: MIMEDX GROUP, INC.; MIMEDX PROCESSING SERVICES, LLC
Reel/Frame 054075/0687 →
PATENT SECURITY AGREEMENT Recorded Jul 2, 2020
From: MIMEDX GROUP, INC.; MIMEDX PROCESSING SERVICES, LLC
To: HAYFIN SERVICES LLP, AS COLLATERAL AGENT
Reel/Frame 053121/0833 →
SECURITY INTEREST Recorded Jun 11, 2019
From: MIMEDX GROUP, INC.
To: BLUE TORCH FINANCE LLC, AS COLLATERAL AGENT
Reel/Frame 049426/0863 →
TERMINATION AND RELEASE OF SECURITY INTEREST IN PATENTS Recorded Jan 24, 2019
From: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
To: MIMEDX GROUP, INC.
Reel/Frame 048121/0835 →
NOTICE OF GRANT OF SECURITY INTEREST IN PATENTS Recorded Oct 15, 2015
From: MIMEDX GROUP, INC.
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 036872/0498 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 29, 2014
From: KOOB, THOMAS J.
To: MIMEDX GROUP, INC.
Reel/Frame 034060/0119 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 29, 2014
From: SURGICAL BIOLOGICS, LLC
To: MIMEDX GROUP, INC.
Reel/Frame 034060/0132 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 30, 2014
From: SNOASIS MEDICAL, INC.
To: SURGICAL BIOLOGICS, LLC
Reel/Frame 033422/0197 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 30, 2014
From: TOFE, ROBERT; CHEN, ELIZABETH
To: SNOASIS MEDICAL, INC.
Reel/Frame 033422/0177 →
Continuity (3)
Provisional Application 61808171 · Apr 3, 2013
Provisional Application 61683699 · Aug 15, 2012
Related Publication 20140067058A1 · Mar 6, 2014
Cited By (2)
US 12,208,180 US 12,551,509